ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 145 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $251,000 | -57.9% | 11,861 | -44.2% | 0.08% | -59.8% |
Q1 2021 | $596,000 | -50.4% | 21,253 | -54.0% | 0.19% | -56.7% |
Q4 2020 | $1,201,000 | -30.1% | 46,181 | 0.0% | 0.45% | -46.0% |
Q3 2020 | $1,717,000 | -27.6% | 46,181 | 0.0% | 0.83% | -34.6% |
Q2 2020 | $2,370,000 | +62.8% | 46,181 | 0.0% | 1.27% | +50.5% |
Q1 2020 | $1,456,000 | -53.8% | 46,181 | -12.6% | 0.84% | -39.1% |
Q4 2019 | $3,150,000 | +62.6% | 52,826 | 0.0% | 1.38% | +70.7% |
Q3 2019 | $1,937,000 | -21.2% | 52,826 | 0.0% | 0.81% | -33.4% |
Q2 2019 | $2,457,000 | +15.8% | 52,826 | 0.0% | 1.22% | +8.5% |
Q1 2019 | $2,121,000 | +113.8% | 52,826 | +145.0% | 1.12% | +29.8% |
Q4 2018 | $992,000 | +99100.0% | 21,562 | 0.0% | 0.86% | +112.5% |
Q3 2018 | $1,000 | 0.0% | 21,562 | 0.0% | 0.41% | -55.2% |
Q2 2018 | $1,000 | -50.0% | 21,562 | -31.7% | 0.91% | -42.7% |
Q1 2018 | $2,000 | -100.0% | 31,562 | -72.6% | 1.59% | -59.5% |
Q4 2017 | $7,594,000 | +289.4% | 115,344 | +383.7% | 3.92% | +433.0% |
Q2 2015 | $1,950,000 | +343.2% | 23,847 | +401.4% | 0.74% | +266.2% |
Q1 2015 | $440,000 | – | 4,756 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |